R&D America’s mental health crisis: Why we need a Moonshot Over the last decade, the United States has invested billions of dollars into cutting edge
Views & Analysis How data is crucial to the relaunch of the Cancer Moonshot In this article, Ben Hargreaves takes a look at the renewed effort to tackle deaths from cancer in the US through the Cancer Moonshot.
News After setback, Rhythm gets good news on Imcivree from FDA Rhythm Pharma has secured the first approval in the US for a drug to treat hypothalamic obesity.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
